Further inquiry note: Branche: Synthetics & Plastics ISIN: AT0000785555 WKN: 870378 Index: WBI, ATX Prime, ViDX Börsen: Börse Frankfurt / stock market Börse Stuttgart / stock market Börse Berlin / free trade Wiener Börse AG / official market ...
Further inquiry note: Andreas Wimmer Member of the Board C-QUADRAT Investment AG Stubenring 2 A-1010 Wien Tel.: +43 1 515 66 316 Mail: a.wimmer@investmentfonds.at www.c-quadrat.com Branche: Financial & Business Services ISIN: AT0000613005 WKN: Index: Prime.market Börsen: Börse Frankfurt / official market Wiener Börse AG / official market ...
Beijing (ots/PRNewswire) - New results from the landmark ONTARGET(R) Trial show that, in Asian patients at high risk of cardiovascular disease (CVD), telmisartan (MICARDIS(R)) 80mg is as effective as, and significantly better tolerated than, ramipril 10mg in reducing the risk of cardiovascular death, heart attack, ...
Further inquiry note: Branche: Chemicals ISIN: AT0000644505 WKN: 852927 Index: WBI Börsen: Börse Berlin / free trade Wiener Börse AG / official dealing ...
Berlin (ots/PRNewswire) - - For non-US Healthcare Media and non-UK Healthcare Media - New Studies Show Benefits of MICARDIS(R) (Telmisartan) in Combination With Amlodipine and Hydrochlorothiazide The results of two new studies of MICARDIS(R) (telmisartan) in free combination with amlodipine or fixed combination with hydrochlorothiazide (HCTZ) 25 mg confirm that a ...
Further inquiry note: Lenzing AG Mag. Angelika Guldt Tel.: +43 (0) 7672-701-2713 Fax: +43 (0) 07672-96301 mailto:a.guldt@lenzing.com Branche: Chemicals ISIN: AT0000644505 WKN: 852927 Index: WBI Börsen: Börse Berlin / free trade Wiener Börse AG / official dealing ...
Ingelheim, Germany (ots/PRNewswire) - - First Ever Study to Demonstrate Efficacy of Pramipexole in Treating RLS-Associated Limb Pain - For Healthcare Media Outside the U.S.A. A new study demonstrating that pramipexole (Mirapexin(R)/Sifrol(R)) can significantly reduce RLS-associated limb pain in patients with ...
Further inquiry note: Branche: Telecommunications Services ISIN: DE0005089031 WKN: 508903 Index: Midcap Market Index, TecDAX, CDAX, HDAX, Prime All Share, Technologie All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Hamburg / free trade Börse Stuttgart / ...
May 14, 2008, at 2:00 pm (CET), at the AUSTRIA CENTER VIENNA, in Bruno-Kreisky-Platz 1, 1220 Vienna, Austria Further inquiry note: OMV Investor Relations: Ana-Barbara Kuncic Tel. +43 1 40 440-21443; e-mail: investor.relations@omv.com Press: Bettina Gneisz-Al-Ani Tel. +43 1 40 440-21660; e-mail: bettina.gneisz@omv.com Thomas Huemer Tel. +43 1 40 440-21660; e-mail: thomas.huemer@omv.com Internet Homepage: ...
Ingelheim, Germany (ots/PRNewswire) - - For Healthcare Media Outside the U.S.A. - Studies Demonstrate Positive and Rapid Impact of Pramipexole on the Core Symptoms of Restless Legs Syndrome and Sleep Disturbance A new study has shown that pramipexole (Mirapexin(R)/Sifrol(R)) can significantly reduce sleep ...
Further inquiry note: Mag. Barbara Hagen-Grötschnig Unternehmenskommunikation WIENER STÄDTISCHE Versicherung AG Vienna Insurance Group A-1010 Wien, Schottenring 30 Tel.: +43 (0)50 350-21027 Fax: +43 (0)50 350 99-21027 E-Mail: b.hagen@staedtische.co.at Branche: Insurance ISIN: AT0000908504 WKN: A0ET17 Index: WBI, ATX Prime, ATX Börsen: Prague Stock Exchange / stock ...
Ingelheim, Germany (ots/PRNewswire) - - For Medical Media, Outside the US Only Boehringer Ingelheim today announced that the European Commission has granted marketing authorisation of the new powerful strength of their fixed dose combination antihypertensive drug MicardisPlus(R) 80/25 in all 27 EU member states. It ...
Further inquiry note: Contact: WIENER STÄDTISCHE Versicherung AG Vienna Insurance Group Barbara Hagen-Grötschnig, MBA Corporate Communications Schottenring 30, 1010 Vienna Tel.: +43 (0)50 350-21027 Fax: +43 (0)50 350 99-21027 E-Mail: b.hagen@staedtische.co.at Branche: Insurance ISIN: AT0000908504 WKN: A0ET17 ...
Further inquiry note: Ulrich Brockmann, Head of Investor Relations, tel: +49 40 270 76 - 442 Branche: Retail ISIN: DE0005772206 WKN: 577220 Index: SDAX, CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Stuttgart / free trade Börse Berlin / regulated ...
- Antitrust authorities clear takerover of APP and WPS joint ventures - Full integration into WACKER Group expected by year-end Further inquiry note: Christof Bachmair Media Relations & Information Tel. +49 89 6279-1830 E-Mail:christof.bachmair@wacker.com Branche: Chemicals ISIN: DE000WCH8881 WKN: WCH888 Index: Midcap Market Index, MDAX, CDAX, Classic All Share, HDAX, Prime All Share Börsen: Börse Frankfurt / ...
- Integrated value chain further strengthened - Increase in polymer sales to approx. 1 billion in 2008 - Another logical step in the Groups growth strategy, says WACKER CEO Further inquiry note: Wacker Chemie AG Corporate Communications Christof Bachmair Tel.: +49 (0) 89 6279-1830 E-Mail: christof.bachmair@wacker.com Air Products and Chemicals, Inc. ...
Further inquiry note: OMV Investor Relations: Ana-Barbara Kuncic Tel. +43 1 40 440-21443; e-mail: investor.relations@omv.com Press: Bettina Gneisz-Al-Ani Tel. +43 1 40 440-21660; e-mail: bettina.gneisz@omv.com Thomas Huemer Tel. +43 1 40 440-21660; e-mail: thomas.huemer@omv.com Internet Homepage: ...
Madrid, Spain (ots/PRNewswire) - - For Non-U.S. Media New data from the combined RESIST studies (RESIST-1 and RESIST-2) show that Aptivus(R) (tipranavir), used with Norvir (ritonavir), provides a superior and durable treatment response for up to three years in treatment- experienced HIV patients versus ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. air transport Hartford (USA)/Hamburg (Germany) (euro adhoc) - After an extensive market survey and flight test, Cessna Aircraft Company, a Textron Inc. (NYSE: TXT) company, announced today it will offer the Thielert (FSE: T3C) turbo diesel engine in its Skyhawk 172S aircraft with deliveries set to begin ...
Ingelheim, Germany (ots/PRNewswire) - Constipation is a condition that we are all familiar with, however, according to new international research from Dulcolax(R), constipation actually affects much more than just bowel movements and can have a severely detrimental impact on people's quality of life, in some cases comparable to that experienced by people suffering from more serious ailments. The Dulcolax(R) survey ...
Sydney, Australia (ots/PRNewswire) - New data from two new studies of Viramune(R) (nevirapine) were presented at the 4th International AIDS Society (IAS) in Sydney, Australia. Results from an extended three-year follow-up analysis of the 2NN study demonstrated that HIV-positive patients taking ...
Ingelheim, Germany (ots/PRNewswire) - - Trial to compare newest protease inhibitors in treatment-experienced patients with resistance to more than one PI Boehringer Ingelheim GmbH announced today that enrollment of the POTENT study will begin in August 2007. POTENT will compare the efficacy and safety ...
Ingelheim, Germany (ots/PRNewswire) - Boehringer Ingelheim GmbH announced today that it has begun to enroll patients in the SPRING study. The SPRING study will be one of the largest racially and gender diverse international studies of highly treatment-experienced HIV-1 infected patients. The trial ...
Ingelheim Am Rhein, Germany (ots/PRNewswire) - - Studies Reinforce the Benefits of Pramipexole From Daytime Symptom Control, Including Afternoon and Early Evening Onset - For Healthcare Media Outside the U.S.A. New data demonstrate that pramipexole (Mirapexin(R)/Sifrol(R)) is also efficacious and ...
Securities Acquisition and Takeover Act announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. offeror: Company: Salzgitter Mannesmann GmbH Address: Eisenhüttenstraße 99, D-38239 Salzgitter Contact: Bernhard Kleinermann, Investor Relations Tel.: ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 28.11.2006 Berlin, November 28, 2006 - In order to be able to keep up with its European competitors in the future, Air Berlin is ordering 60 Boeing 737-800 Next Generation jets. By awarding this ...
Glasgow, Scotland, November 15 (ots/PRNewswire) - - New Sub-analyses Provide Insight into Treatment Benefits New data from the combined RESIST studies (RESIST-1 and RESIST-2) show that Aptivus(R) (tipranavir), used with ritonavir (tipranavir/r) as part of combination antiretroviral therapy, continued to ...
Ingelheim, Germany, November 10 (ots/PRNewswire) - - Millions of People Worldwide Living With RLS to Benefit as Treatment Becomes Globally Available Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved pramipexole, a non-ergot dopamine agonist, for the ...
